Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rani Therapeutics Holdings

0.5719
+0.01192.13%
Volume:337.92K
Turnover:196.54K
Market Cap:19.20M
PE:-0.58
High:0.6000
Open:0.5700
Low:0.5618
Close:0.5600
Loading ...

Rani Therapeutics Holdings Inc. Conducted Annual Stockholders Meeting

Reuters
·
30 May

Rani Therapeutics Secures $4.3M via Series D Warrant

TIPRANKS
·
20 May

Rani Therapeutics Holdings Inc. Announces Share Transactions: Issues Series D Warrant and Lowers Exercise Prices for Series B and C Warrants

Reuters
·
20 May

Rani Therapeutics Announces Research Agreement With Chugai

THOMSON REUTERS
·
19 May

Oppenheimer Adjusts Rani Therapeutics Price Target to $4 From $14, Maintains Outperform Rating

MT Newswires Live
·
16 May

BRIEF-Rani Therapeutics Q1 Net Income USD -12.738 Million

Reuters
·
14 May

Rani Therapeutics Hldgs Q1 EPS $(0.22) Misses $(0.21) Estimate, Sales $172.00K

Benzinga
·
14 May

Press Release: Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update

Dow Jones
·
14 May

Rani Therapeutics Faces Nasdaq Compliance Challenge

TIPRANKS
·
07 May

Rani Therapeutics Price Target Maintained With a $9.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Apr

Rani Therapeutics Holdings: Buy Rating Backed by Strong Financial Position and Promising Clinical Trials

TIPRANKS
·
03 Apr

RANI: 2024 Financial Results

Zacks Small Cap Research
·
01 Apr

Stifel Nicolaus Reaffirms Their Buy Rating on Rani Therapeutics Holdings (RANI)

TIPRANKS
·
01 Apr

Rani Therapeutics Holdings Inc (RANI) Q4 2024 Earnings Call Highlights: Navigating Financial ...

GuruFocus.com
·
01 Apr

BRIEF-Rani Therapeutics Q4 Operating Expenses USD 15.986 Million

Reuters
·
01 Apr

Rani Therapeutics Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
01 Apr

Rani Therapeutics Hldgs Q4 2024 GAAP EPS $(0.27) Misses $(0.25) Estimate

Benzinga
·
01 Apr

Rani Therapeutics Q4 Operating Expenses USD 15.986 Million

THOMSON REUTERS
·
01 Apr

Rani Therapeutics Holdings Inc Q4 Shr View $-0.25 -- Lseg Ibes Data

THOMSON REUTERS
·
01 Apr

Rani Therapeutics Holdings Inc Q4 Shr Loss $0.27

THOMSON REUTERS
·
01 Apr